What is the influence of diabetes on 5-year mortality and morbidity in patients with multivessel disease?
The Bypass Angioplasty Revascularization Investigation (BARI) study found that diabetes had an influence on 5-year mortality and morbidity in patients with multivessel disease. The study found that diabetic patients had a higher risk of death and other adverse events compared to non-diabetic patients. Furthermore, the study found that CABG was more effective than PTCA in reducing the risk of adverse events in diabetic patients.